유전자원에 대한 접근과 이익공유에 관한 미국국립암센터의 수집계약과 INBio-Merck협정의 사례 분석

서지정보

ㆍ발행기관 : 한국국제농업개발학회 ㆍ수록지정보 : 한국국제농업개발학회지 / 29권 / 4호
ㆍ저자명 : 오윤석

목차

재료 및 방법
1. 미국 국립암센터의 유전자원 수집계약
2. INBio-Merck 협정
결과 및 고찰
적 요
ACKNOWLEDGMENTS
REFERENCES

영어 초록

This article study the Letter of Collection(LOC) of U.S. National Cancer Institute(NCI) and the INBio-Merck Agreement as a international cases of the Access to Genetic Resources and Benefit- Sharing. These cases have the matching parts to the provisions of concern international norms. But, these cases not reflected the provisions of international norm because they concluded before 2010. So access to genetic resources and benefit sharing agreement will be concluded in the future must include the following contents. First, the provisions of the provider and the user of genetic resources as a parties of benefit sharing agreement. Second, the provisions of participation of stakeholders. Third, the provisions of prior informed consent. Prior informed consent must provide basic principles, elements, competent national authority granting and information of procedures for obtaining prior informed consent. Fourth, the provisions of mutually agreed terms. Fifth, the incentive measures could be used in the implementation for conservation and sustainable use of biodiversity, to promote accountability of access and benefit sharing, to provide for national monitoring and reporting.

참고 자료

없음